TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

tions does result in clinical failure. Clin Infect Dis 2002;35:565-9.
1.745 Lonks JR et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant
Streptococcus pneumoniae. Clin Infect Dis 2002;35:556-64.
1.746 Chen DK et al. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada.
N Engl J Med 1999;341:233-9.
1.747 Fuller JD et al. A review of Streptococcus pneumoniae infection treatment failures associated with
fluoroquinolone resistance. Clin Infect Dis 2005;41:118-21.
1.748 Clay KD et al. Severe hepatotoxicity of telithromycin: three case reports and literature review. Ann
Intern Med 2006;144:415-20.
1.749 Mills GD et al. Effectiveness of β lactam antibiotics compared with antibiotics active against atypical
pathogens in non-severe community acquired pneumonia: meta-analysis. Br Med J 2005;330:456-
60.
1.750 Oosterheert JJ et al. Effectiveness of early switch from intravenous to oral antibiotics in severe community
acquired pneumonia: multicentre randomised trial. Br Med J 2006;333:1193-7.
1.751 Janssens JP et al. Pneumonia in the very old. Lancet Infect Dis 2004;4:112-24.
1.752 Vanhoof R et al. 10th survey of antimicrobial resistance in noninvasive clinical isolates of Streptococcus
pneumoniae collected in Belgium during winter 2007-2008. Pathol Biol 2010;58:147-51.
1.753 Mykietiuk A et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria
era: the influence of levofloxacin therapy. Clin Infect Dis 2005;40:794-9.
1.754 Blázquez Garrido RM et al. Antimicrobial chemotherapy for legionnaires disease: levofloxacin versus
macrolides. Clin Infect Dis 2005;40:800-6.
1.755 Liapikou A et al. Severe community-acquired pneumonia: validation of the Infectious Diseases Society
of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clin
Infect Dis 2009;48:377-85.
1.756 Niven DJ et al. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
Expert Rev Anti Infect Ther 2009;7:69-81.
1.757 Martínez JA et al. Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated
with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect
Dis 2003;36:389-95.
1.758 Baddour LM et al. Combination antibiotic therapy lowers mortality among severely ill patients with
pneumococcal bacteremia. Am J Respir Crit Care Med 2004;170:440-4.
1.759 Metersky ML et al. Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not
fluoroquinolones. Chest 2007;131:466-73.
1.760 Rodríguez A et al. Combination antibiotic therapy improves survival in patients with community-acquired
pneumonia and shock. Crit Care Med 2007;35:1493-8.
1.761 Blot S et al. Antibiotic therapy for community-acquired pneumonia with septic shock: Follow the guidelines.
Crit Care Med 2007;35:1617-8.
1.762 Mykietiuk A et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria
era: the influence of levofloxacin therapy. Clin Infect Dis 2005;40:794-9.
1.763 Blázquez Garrido RM et al. Antimicrobial chemotherapy for legionnaires disease: levofloxacin versus
macrolides. Clin Infect Dis 2005;40:800-6.
1.764 Kollef MH et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification,
management, and outcomes – proceedings of the HCAP summit. Clin Infect Dis 2008;46
(suppl. 4):S296-334.
1.765 Brito V et al. Healthcare-associated pneumonia is a heterogeneous disease and all patients do not
need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect
Dis 2009;22:316-25.
1.766 Carratalà J et al. What is healthcare-associated pneumonia and how is it managed? Curr Opin Infect
Dis 2008;21:168-73.
1.767 Torres A et al. Defining, treating and preventing hospital acquired pneumonia: European perspective.
Intensive Care Med 2009;35:9-29.
1.768 American Thoracic Society et al. Guidelines for the management of adults with hospital-acquired,
ventilator-associated and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:
388-416.
1.769 Rotstein C et al. Clinical practice guidelines for nosocomial pneumonia and ventilator-associated
pneumonia in adults. Can J Infect Dis Med Microbiol 2008:19:19-53.
1.770 Masterton RG et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report
of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy.
J Antimicrob Chemother 2008;62:5-34.
1.771 Torres A et al. Update in community-acquired and nosocomial pneumonia. Am J Respir Crit Care
Med 2010;181:782-7.
1.772 Niederman MS. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill
patients: maximizing clinical outcomes and minimizing selection of resistant organisms. Clin Infect
Dis 2006;42(suppl. 2):S72-81.
1.773 Levin AS. Nosocomial legionellosis: prevention and management. Expert Rev Anti Infect Ther
2009;7:57-68.
1.774 Grammatikos AP et al. Optimal duration of the antimicrobial treatment of ventilator-acquired pneumonia.
Expert Rev Anti Infect Ther 2008;6:861-6.
1.775 Torres A et al. Defining, treating and preventing hospital acquired pneumonia: European perspective.
Intensive Care Med 2009;35:9-29.
1.776 American Thoracic Society et al. Guidelines for the management of adults with hospital-acquired,
ventilator-associated and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:
388-416.
1.777 Rotstein C et al. Clinical practice guidelines for nosocomial pneumonia and ventilator-associated
pneumonia in adults. Can J Infect Dis Med Microbiol 2008:19:19-53.
1.778 Masterton RG et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report
of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy.
J Antimicrob Chemother 2008;62:5-34.
1.779 Foglia E et al. Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients.
Clin Microbiol Rev 2007;20:409-25.
1.780 Klompas M. Does this patient have ventilator-associated pneumonia? J Am Med Assoc 2007;297:
1583-93.
1.781 Srinivasan R et al. A prospective study of ventilator-associated pneumonia in children. Pediatrics